Dasiprotimut-T

DB17287Experimental

Dasiprotimut-T is a personalized therapeutic vaccine against B-cell lymphomas. It has been investigated in clinical trials.

Also known as
BiovaxID

Resolves to

Clinical / RWD
ATCL03AX19

What you can answer from here — as of April 02, 2025

1ATC codeIncluding every combination product, plus 2 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of Dasiprotimut-T, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In